About
eGlint develops a diagnostic platform that uses aptamer technology to enable fast, low-cost, highly accurate, and multiplex detection of biomarkers.
Explore eGlint's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.